Figure 4
From: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients
Expression of genes in the MUC1-Associated Proliferation Signature (MAPS). Survival and disease-free survival for expressors of the signature (MAPS+, n = 212) compared with non-expressors (MAPS-, n = 229).
